China Renaissance in ‘most challenging period since its establishment’ amid founder’s absence
The investment bank’s revenue fell in the first half as weak demand due to economic uncertainty caused its income from advisory services for private share sales to plunge Key Takeaways:…
FAST NEWS: Hillhouse invests $22 million in Legend Biotech
The latest: Genscript Biotech Corp. (1548.HK) announced on Sunday that its New York-listed subsidiary Legend Biotech Corp. (LEGN.US) has sold 692,782 shares through a private placement to LGN Holdings Ltd.,…
RELATED ARTICLES
-
BRIEF: China Renaissance founder Bao Fan being probed for corruption
1911.HK -
JF SmartInvest makes roaring, yet vulnerable, comeback on China stock rally
9636.HK
-
Hello Group takes its matchmaking skills beyond China
MOMO.US
-
Imax China roars into Year of the Snake after weak performance in 2024
1970.HK
-
Youdao looks to parent, global markets to revive stalling growth
DAO.US
